Cellectis (CLLS) Current Assets (2013 - 2026)

Cellectis' Current Assets history runs 14 years deep, the most recent figure standing at $204.5 million for Q1 2026.

• On a quarterly basis, Current Assets fell 24.75% year-over-year to $204.5 million in Q1 2026; TTM through Mar 2026 was $204.5 million, a 24.75% decrease from a year earlier, with the FY2025 full-year figure at $236.2 million, down 17.7% from the prior year.
• Current Assets retreated to $204.5 million in Q1 2026 per CLLS's latest filing, from $236.2 million in the prior quarter.
• Across five years, Current Assets topped out at $305.8 million in Q2 2024 and bottomed at $96.5 million in Q3 2023.
• The 5-year median for Current Assets is $221.2 million (2025), against an average of $206.0 million.
• Across the five-year window, Current Assets plunged 45.86% in 2022 and soared 205.13% in 2024, its largest moves.
• Year by year, Current Assets stood at $122.0 million in 2022, then jumped by 90.92% to $233.0 million in 2023, then advanced by 23.2% to $287.1 million in 2024, then slipped by 17.7% to $236.2 million in 2025, then fell by 13.42% to $204.5 million in 2026.
• Per Business Quant, the three latest CLLS Current Assets figures stand at $204.5 million (Q1 2026), $236.2 million (Q4 2025), and $221.2 million (Q3 2025).